C Form 4 reports acquisition/exercise transactions

Turek Zdenek reported acquisition or exercise transactions in a Form 4 filing for C. The filing lists transactions totaling 36,392 shares.

Rhea-AI Filing Summary

Turek Zdenek reported acquisition or exercise transactions in a Form 4 filing for C. The filing lists transactions totaling 36,392 shares. Following the reported transactions, holdings were 242,811 shares.

Insider Trade Summary

Grant/Award: 36,392.04 shares

Grant/Award 2 txns

Insider Turek Zdenek

Role Chief Risk Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	36,392.04	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 242,810.84 shares (Direct); Common Stock — 125.693 shares (Indirect, By 401(K))

Footnotes (1)

1. F1. Award of deferred stock pursuant to the Issuer's 2019 Stock Incentive Plan. This award vests in four equal annual installments beginning on January 20, 2027; none of the award is eligible for immediate sale.

FAQ

What insider transaction did Citigroup (C) report for Zdenek Turek?

Citigroup reported that Chief Risk Officer Zdenek Turek received an award of 36,392.04 shares of common stock. The grant was made at a price of $0 as deferred stock under the 2019 Stock Incentive Plan, reflecting equity-based compensation rather than an open-market purchase.

Was the Citigroup (C) insider transaction a stock purchase or a grant?

The transaction was a stock grant, not a market purchase. Zdenek Turek acquired 36,392.04 shares through an award under Citigroup’s 2019 Stock Incentive Plan, coded as an acquisition (grant or award), with a price of $0 per share rather than a cash-paid transaction.

When do Zdenek Turek’s new Citigroup (C) shares vest?

The deferred stock award vests in four equal annual installments starting January 20, 2027. This means the 36,392.04 shares will become available over four years, aligning Turek’s compensation with longer-term company performance rather than providing immediately tradable shares.

Can the newly granted Citigroup (C) shares be sold immediately?

No, none of the awarded shares are eligible for immediate sale. The filing specifies that the deferred stock grant under the 2019 Stock Incentive Plan vests in four equal annual installments from January 20, 2027, so the shares become available gradually over time.

How many Citigroup (C) shares does Zdenek Turek own after this grant?

After the reported grant, Zdenek Turek beneficially owns 242,810.84 Citigroup common shares directly. He also has an indirect holding of 125.693 shares through a 401(k) plan, reflecting both his core equity position and retirement-related holdings in the company.

What role does Zdenek Turek hold at Citigroup (C) in this Form 4?

In this Form 4, Zdenek Turek is identified as Citigroup’s Chief Risk Officer. The reported transaction reflects equity compensation tied to that executive role, granted under the company’s 2019 Stock Incentive Plan, with vesting over four years beginning January 20, 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/13/2026 - 04:08 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Turek Zdenek

(Last) (First) (Middle)

CITIGROUP INC.

388 GREENWICH STREET

(Street)

NEW YORK NY 10013

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CITIGROUP INC [ C ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Risk Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		A		36,392.04(1)	A	$0	242,810.84	D
Common Stock								125.693	I	By 401(K)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Award of deferred stock pursuant to the Issuer's 2019 Stock Incentive Plan. This award vests in four equal annual installments beginning on January 20, 2027; none of the award is eligible for immediate sale.

	Zdenek Turek by Joseph B. Wollard, Attorney-in-Fact	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.